Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Asylia Diagnostics BV logo — Diagnostics technology platform intended to provide safer im...

Asylia Diagnostics BV

Diagnostics technology platform intended to provide safer immunotherapy for cancer patients

Founded 2016 Belgium Belgium 8 employees

General Information

Company Name Asylia Diagnostics BV
Founded Year 2016
Location Belgium Belgium +1
Employees 8
Social

Get notified when Asylia Diagnostics BV moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Asylia Diagnostics BV

Asylia, a precision medicine platform, leverages generative AI and multi-modal molecular data to revolutionize immunotherapy safety and efficacy. We provide molecular diagnostics for cancer patients and drug developers, optimizing treatment and boosting clinical trial success.

No funding data available for Asylia Diagnostics BV yet.

Get notified when Asylia Diagnostics BV raises funding

Asylia Diagnostics BV Alternatives & Competitors

Asylia Diagnostics BV vs
UgenTec
UgenTec Belgium

Sample Flow Intelligence

Acquired
3 employees
Biotechnology, Health Care
Asylia Diagnostics BV vs
Molecular Health
Molecular Health Germany

We are dedicated to building software solutions that transform biomedical data into actionable insig...

Private Equity
71 employees
Biotechnology, Health Care
Asylia Diagnostics BV vs
Geneplus-Beijing Co. Ltd.
Geneplus-Beijing Co. Ltd.

Pioneering innovative molecular biological solutions for life science and diagnostics

Series C
Biotechnology, Health Care

FAQ About Asylia Diagnostics BV

Diagnostics technology platform intended to provide safer immunotherapy for cancer patients
Asylia Diagnostics BV was founded in 2016.
Asylia Diagnostics BV is headquartered in Belgium.
Asylia Diagnostics BV has approximately 8 employees.
Top alternatives and competitors to Asylia Diagnostics BV include UgenTec, Molecular Health, Geneplus-Beijing Co. Ltd., Luoyang Jalon Micro-nano New Materials Co., Ltd., Society of Nuclear Medicine and Molecular Imaging (SNMMI). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Asylia Diagnostics BV and UgenTec are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Asylia Diagnostics BV and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy